Belong group – Melanoma MD
Prof. Michal Lotem is the head of the center for melanoma and Cancer Immunotherapy at the Hadassah Medical Center. Prof. Lotem participated in pivotal clinical trials that led to FDA’s approvals and is conducting anti-cancer vaccination protocols. Most recent is the use of engineered cancer cells with improved properties of activating immune cells. Prof. Lotem graduated at the Sackler School of Medicine, Tel Aviv University, has a Board Certification in Dermatology and Clinical and Radiation Oncology. She conducted her post-doctoral research fellowship at NCI, Bethesda, MD and is a visiting professor at Ronald Levy’s lab, pioneer of Monoclonal antibody-based lymphoma therapy and cancer immunotherapy, Stanford, CA. Prof. Lotem’s belief is that researcher clinicians should be the motivating force to guide scientific research to meet the acute needs of developing and advancing cancer cure.

Belong group – Head & Neck Cancers MD
Prof. Aron Popovtzer graduated from Hebrew University, School of Medicine and completed his residency in Otolaryngology and H&N Surgery in Rabin Medical Center, followed by residencies in both Medical and Radiation oncology which he completed in the Davidoff Cancer center. He completed a two year fellowship in Head and neck cancer in the University of Michigan Ann Arbor and Brachytherapy Fellowship in Memorial Sloan Kettering NYC. Prof. Popovtzer is Head of the Sharett institute of Oncology, ENT, Medical & radiation oncologist specialist. Prof. Popovtzer is also the Chairman of the Israel Head and Neck Society, and an active member in the American Head and Neck Society and the EORTC. He has published over 60 papers and is an associate clinical Professor in the Tel Aviv University. His research focuses on tailored medicine for radiosentization genomic sequencing in unusual carcinomas and highly conformal irradiation of head and neck cancer.

Belong group – Eye Cancers
Prof. Shahar Frenkel is a clinician-scientist, an Ocular Oncologist and Ophthalmic Pathologist, and the head of the Ocular Oncology Laboratory at the Hadassah-Hebrew University Medical Center. He is a graduate of the Hebrew University in Jerusalem’s MD-PhD program. He was trained at Hadassah, Jerusalem, Israel, and at UIC, Chicago, IL, USA. Prof. Frenkel served on the board of the International Society of Ocular Oncology and is currently on the board of the Israeli Society for Vision and Eye Research. Prof. Frenkel diagnoses and treats any kind of eye cancer, he developed surgical techniques for the treatment of eye cancers, and he is striving to develop new biological therapies for cancer. Prof. Frenkel is the consulting Ophthalmologist for clinical trials for a variety of cancers.

Belong group – Colo-Rectal Cancer MD, Neuro Endocrine Tumors MD
Prof. Ravit Geva is a medical oncologist, Head of GIT malignancies Center, Head of Research Unit, Deputy Director Division of Oncology. She graduated medical school with honors at the Ben-Gurion University and followed by a residency in Medical oncology in the Tel-Aviv Sourasky Medical center. Prof. Geva did a fellowship in GIT malignancies under the guidance of prof. Eric Van Cutsem in the Clinical Digestive Oncology Department in Leuven, Belgium. She further specialized in the development of investigational drugs and clinical trials in Oxford University where she did her MSc in Experimental Therapeutics. Prof. Geva heads the Gastrointestinal Malignancies Center as well as the Oncology Research Unit at the Tel-Aviv Sourasky medical center in Israel. She is the chair of CTrials, The Israeli Association for Research and the Advancement of the Biomedical Community.

Belong group – Children Oncology MD
Prof. Ronit Elhasid Head of the Pediatric hemato-oncology and bone marrow transplant department at the Tel Aviv Sourasky Medical Center, since 2011. Prof. Ronit Elhasid has been treating children with Leukemia and those undergoing stem cell transplants for over two decades. Since 2014, she is serving as the head of the national protocol for ALL relapse during childhood which is part of the international protocol. Throughout the years, she has been taking part in dozens of clinical trials and participating in multiple professional associations, worldwide. Prof. Ronit Elhasid his a senior lecturer at the Sackler Faculty of Medicine.

Belong group – Neurosurgical MD

Medical Director of Neurosurgery and Neuro-oncology at Novocure. His area of interest is malignant brain tumors, and he led the largest recent trial on Glioblastoma with the use of Tumor Treating Fields (Trident trial). Dr. Lustgarten completed his neurosurgical training in Caracas, Venezuela and at the Radcliffe Infirmary (University of Oxford) under the sponsorship of the Royal College of Surgeons of England and General Medical Council (UK). He has over 23 years of neurosurgical and radiosurgical experience in the treatment of malignant and benign brain tumors. He has published extensively in scientific journals and book chapters and lectured internationally. Active member of various Neurosurgical Societies and a neurosurgical consultant to various academic institutions.

Belong group – Orthopaedic-Oncology MD

Chief of Orthopedic Oncology Service at Mount Sinai Hospital in New York. He specializes in the treatment of benign and malignant tumors of bone and soft tissue in patients of all ages. He treats tumors that arise within muscle and bone, such as sarcomas, as well as cancers that spread to bone, such as lung, breast, prostate, and kidney cancer. The treatment options range from observation to minimally invasive procedures to extensive limb sparing surgeries.

Dr. Lofin undergraduate at Princeton University and his medical training was at Washington University School of Medicine. He completed residency in orthopedic surgery at NYU Hospital for Joint Diseases followed by fellowship in orthopedic oncology at The Washington Hospital Center/Georgetown University.

Dr. Moti Avner is a Melanoma & Immunotherapy specialist. He is a senior medical oncologist at Sharet Institute, at Hadassah medical center, Jerusalem. Dr. Avner has a special interest in cancer genetics, cancer in young adults, and health services digitation.

Belong group – Colo-Rectal Cancer MD

A senior oncologist at the Gastrointestinal Tumors Unit, in the Tel Aviv Medical Center, Ichilov.  He treats patients diagnosed with colon cancer, rectal cancer, and various tumors in the upper GI tract, including pancreatic and biliary tract tumors. As part of his work at the clinic, he integrate clinical research and take an active part in clinical studies, and serves as a sub-investigator in first phase studies in the Ichilov research unit.

Dr. Mirelman finished his medical studies in the 4-year program at Tel Aviv University and started an internship in the oncology unit in Ichilov. He participates in tumor boards and in multidisciplinary meetings. He participates in conferences in Israel and around the world, dealing with tumors of the GI tract.

Belong group – Sarcoma MD
Dr. Eytan Ben-Ami is Deputy of Cancer Division at Sheba Medical Center. He completed medical oncology residency at the Chaim Sheba Medical Center in 2015. Between 2015-2018 he worked as a research scholar in the department for sarcoma and bone oncology at the Dana-Farber Cancer Institute in Boston, where he focused his research on investigational therapies in patient derived xenograft models (PDX) in mice, as well as the potential of targeted therapies in the various sarcoma subtypes. Dr. Eytan Ben-Ami clinical focus is on the multidisciplinary and treatment approach to localized and advanced soft-tissue and bone sarcomas in adults.

Belong group – Lung Cancer MD.
Dr. Maya Gottfried is the Director of the Oncology Institute at the Meir Medical Centre and a Senior Lecturer at the Tel Aviv School of Medicine. She completed her MD at the University of Padua, Italy and became a Senior Specialist in Internal Medicine at the Meir Medical Centre and later Chief Resident in the Oncology Department at Sheba Medical Centre and Instructor of Internal Medicine at the Tel Aviv School of Medicine. She completed a Fellowship in Medical Oncology at the Institute of Oncology Gustave-Roussy, in France, before returning as Chief Resident to the Oncology Department of Sheba Medical Centre and Meir Medical Centre. Dr Gottfried was appointed Senior Specialist in Oncology and Radiation at the Sheba and Meir Medical Centres, and later as Head of the Lung Oncology Unit at the Meir Medical Centre. Dr Gottfried has been involved extensively in clinical trials on non-small cell lung cancer acting as Principal Investigator. She is a member of many associations worldwide.

Belong group – Surgical Oncology MD
Dr. Ron Lavy is the Head of Surgery B at Shamir Medical Center, Israel. He received his MD degree from Tel Aviv Sackler school of Medicine and completed residency training at Assaf Harofeh. Dr. Lavy completed his 2 years fellowship in the Dep. of Surgical Oncology at the University of Illinois, Chicago, before returning as a senior general surgery to Assaf Harofeh. Dr. Lavy has been involved in the publications of many professional papers and is a member in the Israeli Medical Association, Surgical Association, Israel society of Surgical Oncology and the Israel society of Colorectal Surgery.

Belong group – Kidney & Bladder Cancer MD
Dr. Avivit Peer is a senior doctor at the Oncology Division at Rambam Medical Center, in charge of the kidney and urinary cancer clinic, and heads the oncology clinical trial unit. She graduated life science studies and med school with honors and specialized in oncology at the Rambam Medical Center. She studied the field of clinical trials in France and testicular cancer in the US. She lectures at the medical faculty of the Technion Institute, and received several recognition awards for her activity in medical education. She is a member in several oncology associations in Israel and the US. Alongside patient treatment and clinical trials, Dr. Peer’s center of activity is the development of oncology clinical trial methods, including research into groundbreaking cancer drugs and early stage drug effect on cancer patients and its effect on new drug development.

Belong group – Ask the Oncologist
Dr. Daniel A. Vorobiof founder of the Sandton Oncology Centre in Johannesburg, South Africa since 1989 until 2018. Dr. Daniel A. Vorobiof completed his MD degree from the University of Cordoba, Argentina, and a Doctor in Medicine degree from the University of Pretoria, South Africa. He have been working in Medical Oncology since 1980, a member of several national and international oncologic societies. Currently he is a member of the European School of Oncology (ESO) Core Faculty in Breast Cancer and Malignant Melanoma. He is also on the Editorial Board of various international oncologic medical journals and the editor of 2 magazines.He was a founder member and a chairman of several South African Medical Oncology Societies, He had been involved in clinical research nationally and internationally and published more than 100 research articles in medical oncology journals.

Belong group – Cardio-Oncology MD
Dr. Luba Vasilenko, Head of the Intermediate Cardiac Care Unit and the chairman of the Cardio-Oncologic Clinic at the Assuta Ashdod Medical Center. Dr. Luba Vasilenko completed his MD degree at the Altaisk Medical Royal University in Russia. He completed his internal medicine residence at the Sheba Medical Center and the cardiology residence at the Hillel Yaffe Medical Center.He has more than ten years of experience as a cardiologist and have been working in Cardio-Oncologic clinics since 2014. I published several papers and am involved in several clinical trials. Dr. Luba Vasilenko is active member of the European Cardiology Society.

Belong group – Stomach & Esophageal Cancer MD
Dr. Ofer Purim is the Chief of the gastrointestinal malignancy service at the new Assuta University Hospital. He graduated with honors at the Szeged University in Hungary, completed his residency at the Davidoff Cancer Center at the Beilinson Hospital and worked as a senior physician at the Davidoff center in the gastrointestinal unit. Dr. Purim specializes in treatment of rare tumors of the GI tract such as GIST and neuroendocrine tumors and has over 14 years of experience in the field. Dr. Purim is very active in researches and served as a primary investigator and sub investigator in dozens of local and international trials. He has published 32 manuscripts in his field and is a lecturer to physicians, nurses and for the public. Dr. Purim is a member of the Executive Committee of the Israeli Society for Oncology and Radiotherapy.

Belong group – Neuro Endocrine Tumors MD
Dr. Esther Osher, is the head of the neuroendocrine tumor unit at the Institute of Endocrinology , Tel Aviv Souraski Medical Center(TASMC). Graduated medical School, at the Technicon Haifa, and PhD degree at Sackler Faculty of Medicine, Tel -Aviv University. She is a specialist in Internal medicine and Endocrinology since 2002, since then she is a senior physician at the institute of endocrinology at TASMC. Dr. Osher is a member in several medical associations in Israel and worldwide, published medical papers and a lectures at the Sackler School of Medicine TAU.

Belong group – Prostate & Testicular Can. MD
Dr. Daniel Keizman, is the Head of the Genitourinary Oncology Unit, at the Division of Oncology, at the Tel-Aviv Sourasky Medical Center, Israel. Dr Keizman graduated from the Sackler Faculty of Medicine, Tel Aviv University. He is board certified in internal medicine and medical Oncology (trained at the Tel-Aviv Sourasky Medical Center). He did his post doctoral clinical fellowship in genitourinary oncology during the years 2008-2001 at the Kimmel Cancer Center, Johns Hopkins Hospital, Baltimore, USA. Dr Keizman’s current research activity, focuses on genitourinary oncology. He is the author of numerous studies and review articles published in medical journals, and presented numerous studies in international meetings. He is a member of the American Society of Clinical Oncology and the Israel Society of Clinical Oncology

Belong group – Children Oncology MD
Yair Peled. a senior doctor at the pediatric hemato-oncology and bone marrow transplant department at the Tel Aviv Sourasky medical center. Dr. Yair Peled treat pediatric patients that suffer from solid tumors and mainly sarcomas. He graduated from medical school at the Hebrew University, completed his residency in pediatrics at Sha’arei Tzedek medical center, and graduated pediatric hematology and oncology residency at the Hadassah medical center.

Belong group – Prostate & Testicular Can. MD, Kidney & Bladder Cancer MD
Dr. Tomer Charas, Heads of the Genitourinary oncology unit at the Oncology Division at the Rambam Health Care Campus, Haifa, Israel. He is a board-certified radiation oncologist, specializing in radiation therapy treatments of the genitourinary tract cancers. He graduated from Semmelweis University medical school, Budapest, Hungary with honors. After completing his radiation oncology residency training at Rambam Health Care Campus, He completed radiation oncology Genitourinary fellowship program and additionally Brachytherapy fellowship program, both at Memorial Sloan Kettering Cancer Center NYC, NY. He’s involved in prostate brachytherapy (implanting radioactive sources in the prostate – a minimally invasive procedure), SBRT (highly focused radiotherapy treatments), researching and implementing new technologies aiming to improve patients’ care and reduce side effects from treatments. Dr. Charas is a member of the EORTC, ABS and Amercian Society for Radiation Oncology (ASTRO).

Belong group – Kidney & Bladder Cancer MD
Dr. Roy Mano serves as an attending physician in the Urology Department at Tel-Aviv Sourasky Medical Center. He is a board certified urologist focused on the treatment of patients with urologic malignancies including bladder, kidney and prostate cancers. Dr. Mano received his medical degree from The Ruth & Bruce Rappaport Faculty of Medicine at the Technion – Israel Institute of Technology where he graduated with honors. After finishing the Urology residency training program at Rabin Medical Center, he completed a two year Society of Urologic Oncology fellowship at Memorial Sloan Cancer Center in New York. During his fellowship he trained in both open and robotic surgeries for the treatment of urologic malignancies. In addition to his clinical duties Dr. Mano is involved in clinical and translational research focused on bladder and kidney cancer, with the aim of improving our ability to personalize treatment options for patients diagnosed with cancers involving the genito-urinary tract

Belong Group – Liver & Bile Duct Cancer MD
Dr. Margalit is a senior physician-scientist in the field of medical oncology at Sheba Medical Center, specializing in gastrointestinal malignancies, in particular hepatocellular carcinoma, and cholangiocarcinoma.

He graduated from Tel-Aviv University Medical School in Israel and completed his post-doctoral studies at MD Anderson Cancer Center, Houston, TX. He published over 45 peer-reviewed articles and is a member of the American Society of Clinical Oncology (ASCO) and the American Association of Cancer Research (AACR).